Though Systolic BP Seems More Important, Diastolic BP Should Not Be Disregarded

Systolic hypertension is more often associated to cardiovascular events. However, diastolic blood pressure should not be disregarded, since it can also predict even worse outcomes.

Oportunidades perdidas en pacientes con enfermedad vascular periférica

Although systolic blood pressure is very frequently associated to adverse cardiovascular events, by no means should diastolic blood pressure be considered unimportant.

Such is the message of this study recently published in NEJM including data from more than 1.3 million outpatients, which shows that both systolic and diastolic hypertension are independently associated to cardiovascular events in the long run (acute myocardial infarction, ischemic or hemorrhagic stroke) regardless the type of blood pressure we might be focusing on.

Diastolic pressure should not be ignored, and we should focus on both BP goals (systolic and diastolic) for both hypertension diagnosis and treatment, to maximize the chances of therapy and effectively reduce population risk. According to the study authors, the AHA/ACC goals are reasonable and well founded, which is why they suggest aggressive treatment, especially when it comes to higher risk patients.


Read also: Dietary Supplements and Diets Show No Impact on Cardiovascular Risk.


They believe the J shaped curve should be of no concern.

The analysis included 36.8 million registries on blood pressure automatically measured. Using 140/90 as threshold, 18.9% presented hypertension, but when using 130/80 the incidence increased to 43.5%!!!

Regardless the BP definition we might choose, both systolic and diastolic pressure are independently associated to adverse events at 8 year follow up.

The correlation was stronger for systolic blood pressure.


Read also: Supervised Exercise and Revascularization for Intermittent Claudication.


The authors also explored the J shape curve previously observed between diastolic BP and events. This non-adjusted analysis showed increased risk both for peak and valley thresholds, but when adjusting by age, race and other comorbidities, the risk at the bottom of the curve disappeared.

According to this study, the J shape in this population (mostly healthy, mean age 53) is not a problem, so we should be more aggressive in trying to reach the proposed goals with no regard of the J curve, since after adjusting for variables, the risk in the lowest quartile disappears.

Título original: Effect of systolic and diastolic blood pressure on cardiovascular outcomes.

Referencia: Flint AC et al. N Engl J Med. 2019;381:243-251.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

EuroPCR 2026 | P2Y12 Inhibitor Monotherapy After Complex PCI in ACS: Results From the NEO-MINDSET COMPLEX Subanalysis

This is a summary of the NEO-MINDSET COMPLEX subanalysis, presented by Dr. Guy Prado at EuroPCR 2026, which evaluated P2Y12 inhibitor monotherapy versus dual...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...